AVEO Oncology (AVEO) reported Q1 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $20.9 million versus the consensus estimate of $20.65 million.
GUIDANCE:
AVEO Oncology sees FY2022 revenue of $100-110 million.